Market Tracker

06/24 5:16pm ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

20.27
Delayed Data
As of Jun 24
 -1.98 / -8.90%
Today’s Change
20.21
Today|||52-Week Range
263.81
-80.06%
Year-to-Date
We Like Valeant Pharmaceuticals for a Trade (Video)
Jun 24 / Investing Channel - Paid Partner Content
Valeant Pharmaceuticals (VRX) Stock Rating Downgraded at JPMorgan
Jun 23 / TheStreet.com - Paid Partner Content
Steve Mandel Exits Position in Williams Companies in 1st Quarter
Jun 24 / GuruFocus News - Paid Partner Content
3 Stocks That Have Been Cut in Half This Year
Jun 23 / MotleyFool.com - Paid Partner Content
This Merger Could Mean Returns Of Up To 40%
Jun 24 / StreetAuthority - Paid Partner Content
Valeant Enlists Former Tyco Exec for More Help With Accounting
Jun 22 / TheStreet.com - Paid Partner Content
Better Buy: Valeant Pharmaceuticals International, Inc. vs. Allergan
Jun 23 / MotleyFool.com - Paid Partner Content
Jim Cramer's 'Mad Money' Recap: 'Brexit' Means Nothing to U.S. Stocks
Jun 21 / TheStreet.com - Paid Partner Content
Forget a 'Flash Crash'; How About a 'Flash Squeeze' Instead?
Jun 23 / TheStreet.com - Paid Partner Content
After-Hours Trading Shows Valeant Pharmaceuticals International (VRX) Lagging
Jun 21 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close22.25
Today’s open21.16
Day’s range20.21 - 21.48
Volume27,977,033
Average volume (3 months)31,452,204
Market cap$6.9B
Dividend yield--
Data as of 4:02pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-131.25%
Earnings growth (this year)-34.39%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+26.42%
P/E ratioNM
Price/Sales3.32
Price/Book1.18

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...-0.74-1.54%
IDXXIDEXX Laboratories I...-3.91-4.27%
ALKSAlkermes Plc-1.47-3.36%
MNKMallinckrodt Plc-2.75-4.68%
Data as of 4:02pm ET, 06/24/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$1.62
Annual revenue (last year)$10.4B
Annual profit (last year)-$291.7M
Net profit margin-2.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer, Director &
Senior VP
Robert L. Rosiello
Corporate headquarters
Laval, Quă©bec

Forecasts